CandlesenseCandlesense
CNMD•benzinga•

UPDATE: CONMED Raises FY22 Sales Guidance From $1.075B-$1.125B To $1.105B-$1.15B vs $1.09B Est. Adj. EPS From $3.60-$3.85 To $3.50-$3.65 vs $3.69 Est.

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 4, 2022 by benzinga

← Back to CNMD News
    UPDATE: CONMED Raises FY22 Sales Guidance From $1.075B-$1.125B To $1.105B-$1.15B vs $1.09B Est. Adj. EPS From $3.60-$3.85 To $3.50-$3.65 vs $3.69 Est. | CNMD Stock News | Candlesense